Related references
Note: Only part of the references are listed.Systematic review of the radiomics quality score applications: an EuSoMII Radiomics Auditing Group Initiative
Gaia Spadarella et al.
EUROPEAN RADIOLOGY (2023)
Discovery of Pre-Treatment FDG PET/CT-Derived Radiomics-Based Models for Predicting Outcome in Diffuse Large B-Cell Lymphoma
Russell Frood et al.
CANCERS (2022)
Minimizing acquisition-related radiomics variability by image resampling and batch effect correction to allow for large-scale data analysis
Marta Ligero et al.
EUROPEAN RADIOLOGY (2021)
Optimal method for metabolic tumour volume assessment of cervical cancers with inter-observer agreement on [18F]-fluoro-deoxy-glucose positron emission tomography with computed tomography
Mubarik A. Arshad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review
R. Frood et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
A Systematic Review of PET Textural Analysis and Radiomics in Cancer
Manuel Pineiro-Fiel et al.
DIAGNOSTICS (2021)
Temporal improvements in loco-regional failure and survival in patients with anal cancer treated with chemo-radiotherapy: treatment cohort study (1990-2014)
Hema Sekhar et al.
BRITISH JOURNAL OF CANCER (2020)
Trends in incidence of anal cancer in Austria, 1983-2016
Emily Heer et al.
WIENER KLINISCHE WOCHENSCHRIFT (2020)
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping
Alex Zwanenburg et al.
RADIOLOGY (2020)
Radiomics and Machine Learning in Anal Squamous Cell Carcinoma: A New Step for Personalized Medicine?
Nicolas Giraud et al.
APPLIED SCIENCES-BASEL (2020)
A review of original articles published in the emerging field of radiomics
Jiangdian Song et al.
EUROPEAN JOURNAL OF RADIOLOGY (2020)
Radiomics in medical imaging-how-to guide and critical reflection
Janita E. van Timmeren et al.
INSIGHTS INTO IMAGING (2020)
Treatment outcome after radiochemotherapy in anal cancer patients staged with 18F-FDG-PET-CT
L. H. Braun et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2020)
Early stage anal margin cancer: towards evidence-based management
A. G. Renehan et al.
COLORECTAL DISEASE (2019)
Anal cancer chemoradiotherapy outcome prediction using 18F-fluorodeoxyglucose positron emission tomography and clinicopathological factors
Espen Rusten et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Prediction of outcome in anal squamous cell carcinoma using radiomic feature analysis of pre-treatment FDG PET-CT
P. J. Brown et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial
Michael Peter Jones et al.
RADIATION ONCOLOGY (2019)
Vulnerabilities of radiomic signature development: The need for safeguards
Mattea L. Welch et al.
RADIOTHERAPY AND ONCOLOGY (2019)
LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity
Christophe Nioche et al.
CANCER RESEARCH (2018)
Tracking tumor biology with radiomics: A systematic review utilizing a radiomics quality score
Sebastian Sanduleanu et al.
RADIOTHERAPY AND ONCOLOGY (2018)
A core outcome set for clinical trials of chemoradiotherapy interventions for anal cancer (CORMAC): a patient and health-care professional consensus
Rebecca Fish et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2018)
International trends in anal cancer incidence rates
Farhad Islami et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Radiomics: the bridge between medical imaging and personalized medicine
Philippe Lambin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Net benefit approaches to the evaluation of prediction models, molecular markers, and diagnostic tests
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
The rising incidence of anal cancer in England 1990-2010: a population-based study
J. R. Wilkinson et al.
COLORECTAL DISEASE (2014)
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
Robert Glynne-Jones et al.
RADIOTHERAPY AND ONCOLOGY (2014)
Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients with Squamous Cell Carcinoma of the Anal Canal
Jose G. Bazan et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Reference Range for Intrapatient Variability in Blood-Pool and Liver SUV for 18F-FDG PET
Raef R. Boktor et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2x2 factorial trial
Roger D. James et al.
LANCET ONCOLOGY (2013)
Radiomics: the process and the challenges
Virendra Kumar et al.
MAGNETIC RESONANCE IMAGING (2012)
The value of progression-free survival to patients with advanced-stage cancer
Lesley J. Fallowfield et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
MAGNETIC RESONANCE IMAGING ASSESSMENT OF SQUAMOUS CELL CARCINOMA OF THE ANAL CANAL BEFORE AND AFTER CHEMORADIATION: CAN MRI PREDICT FOR EVENTUAL CLINICAL OUTCOME?
Vicky Goh et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Share Paper
